Patricia A. Schreck
Keine laufenden Positionen mehr
Profil
Patricia A.
Schreck worked as a Secretary, EVP & General Counsel at Incyte Corp.
from 2003 to 2011.
She also worked as a General Counsel at diaDexus, Inc. and Genomics Collaborative, Inc. and as a Chief Patent Counsel at Elan Drug Delivery, Inc. Schreck received an undergraduate degree from The University of Colorado and a graduate degree from Villanova University.
Ehemalige bekannte Positionen von Patricia A. Schreck
Unternehmen | Position | Ende |
---|---|---|
INCYTE CORPORATION | General Counsel | 01.01.2011 |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | General Counsel | - |
Elan Drug Delivery, Inc.
Elan Drug Delivery, Inc. Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Elan Drug Delivery, Inc. is engaged in manufacturing, fabricating, or processing drugs in pharmaceutical preparations for human or veterinary use. The company is based in King Of Prussia, PA. | Corporate Officer/Principal | - |
Genomics Collaborative, Inc.
Genomics Collaborative, Inc. Medical SpecialtiesHealth Technology Genomics Collaborative, Inc. provides clinical samples and applies human genetics to target validation for drug discovery. The company is based in Cambridge, MA. The company was founded by Phyllis I. Gardner and Edward E. Harlow. Genomics Collaborative was acquired by BioServe Biotechnologies Ltd., a SUB of ReproCELL, Inc. from SeraCare Life Sciences, Inc. on May 29, 2007 for $2 million. | General Counsel | - |
Ausbildung von Patricia A. Schreck
The University of Colorado | Undergraduate Degree |
Villanova University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
INCYTE CORPORATION | Health Technology |
Private Unternehmen | 3 |
---|---|
Genomics Collaborative, Inc.
Genomics Collaborative, Inc. Medical SpecialtiesHealth Technology Genomics Collaborative, Inc. provides clinical samples and applies human genetics to target validation for drug discovery. The company is based in Cambridge, MA. The company was founded by Phyllis I. Gardner and Edward E. Harlow. Genomics Collaborative was acquired by BioServe Biotechnologies Ltd., a SUB of ReproCELL, Inc. from SeraCare Life Sciences, Inc. on May 29, 2007 for $2 million. | Health Technology |
Elan Drug Delivery, Inc.
Elan Drug Delivery, Inc. Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Elan Drug Delivery, Inc. is engaged in manufacturing, fabricating, or processing drugs in pharmaceutical preparations for human or veterinary use. The company is based in King Of Prussia, PA. | Health Technology |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | Health Technology |